Drugs / Immunoglobulin of cured patients
Immunoglobulin of cured patients
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04264858 | Mar → Apr 2020 | COVID-19 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Immunoglobulin of cured patients | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04264858 ↗ |
| Action | Inhibit | “could block the infection of 2019-nCoV on the host cells” NCT04264858 ↗ |
| Modality | Protein / enzyme biologic | “specific antibodies against virus antigen” NCT04264858 ↗ |
| Route | Intravenous | “0.2g/kg, ivdrip, once a day, for 3 days” NCT04264858 ↗ |